title: Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings.
authors.affiliation: Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. taniken@bioreg.kyushu-u.ac.jp
authors.forename: Kenzaburo
authors.initials: K
authors.lastname: Tani
authors.forename: Miyuki
authors.initials: M
authors.lastname: Azuma
authors.forename: Yukoh
authors.initials: Y
authors.lastname: Nakazaki
authors.forename: Naoki
authors.initials: N
authors.lastname: Oyaizu
authors.forename: Hidenori
authors.initials: H
authors.lastname: Hase
authors.forename: Junko
authors.initials: J
authors.lastname: Ohata
authors.forename: Keisuke
authors.initials: K
authors.lastname: Takahashi
authors.forename: Maki
authors.initials: M
authors.lastname: OiwaMonna
authors.forename: Kisaburo
authors.initials: K
authors.lastname: Hanazawa
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Wakumoto
authors.forename: Kouji
authors.initials: K
authors.lastname: Kawai
authors.forename: Masayuki
authors.initials: M
authors.lastname: Noguchi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Soda
authors.forename: Reiko
authors.initials: R
authors.lastname: Kunisaki
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Watari
authors.forename: Satoshi
authors.initials: S
authors.lastname: Takahashi
authors.forename: Utako
authors.initials: U
authors.lastname: Machida
authors.forename: Noriharu
authors.initials: N
authors.lastname: Satoh
authors.forename: Arinobu
authors.initials: A
authors.lastname: Tojo
authors.forename: Taira
authors.initials: T
authors.lastname: Maekawa
authors.forename: Masazumi
authors.initials: M
authors.lastname: Eriguchi
authors.forename: Shinji
authors.initials: S
authors.lastname: Tomikawa
authors.forename: Hideaki
authors.initials: H
authors.lastname: Tahara
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Inoue
authors.forename: Hiroki
authors.initials: H
authors.lastname: Yoshikawa
authors.forename: Yoshitsugu
authors.initials: Y
authors.lastname: Yamada
authors.forename: Aikichi
authors.initials: A
authors.lastname: Iwamoto
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Hamada
authors.forename: Naohide
authors.initials: N
authors.lastname: Yamashita
authors.forename: Koh
authors.initials: K
authors.lastname: Okumura
authors.forename: Tadao
authors.initials: T
authors.lastname: Kakizoe
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Akaza
authors.forename: Makoto
authors.initials: M
authors.lastname: Fujime
authors.forename: Shirley
authors.initials: S
authors.lastname: Clift
authors.forename: Dale
authors.initials: D
authors.lastname: Ando
authors.forename: Richard
authors.initials: R
authors.lastname: Mulligan
authors.forename: Shigetaka
authors.initials: S
authors.lastname: Asano
mesh_terms: D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D016516:CD4-CD8 Ratio; D019496:Cancer Vaccines / Q000009:adverse effects / Q000235:genetics / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000276:immunology* / Q000378:metabolism / Q000628:therapy*; D016207:Cytokines / Q000276:immunology; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics*; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D008175:Lung Neoplasms / Q000556:secondary; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000032:analysis; D012882:Skin Tests; D014161:Transduction, Genetic; D014611:Vaccination / Q000379:methods
chemical_list: D015703:Antigens, CD; D019496:Cancer Vaccines; D016207:Cytokines; D006684:HLA-DR Antigens; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016178:Granulocyte-Macrophage Colony-Stimulating Factor